William C. Reinhold

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• TRPM4 Expression as a Predictive Biomarker and a Mechanistic Driver of Acetalax Activity in Prostate Cancer: Preclinical Efficacy Studies

  Molecular Cancer Therapeutics · 2026-04-22

• Abstract 7717: TRPM4 expression predicts Acetalax sensitivity in prostate cancer

  Cancer Research · 2026-04-03

• Abstract 3138: CellMiner Cross-Database (CellMinerCDB) for Exploration of Patient-Derived Cancer Cell Line Pharmacogenomics

  Cancer Research · 2026-04-03

• A genome-wide RNAi screen for novel CIN genes using human artificial chromosome

  PNAS Nexus · 2025-12-01

• Supplementary Text from CellMinerCDB: NCATS Is a Web-Based Portal Integrating Public Cancer Cell Line Databases for Pharmacogenomic Explorations

  2025-11-24

• Supplementary Table 2 from CellMinerCDB: NCATS Is a Web-Based Portal Integrating Public Cancer Cell Line Databases for Pharmacogenomic Explorations

  2025-11-24

• Supplementary Figure 1 from CellMinerCDB: NCATS Is a Web-Based Portal Integrating Public Cancer Cell Line Databases for Pharmacogenomic Explorations

  2025-11-24

• Supplemental Figure 2 from CellMinerCDB: NCATS Is a Web-Based Portal Integrating Public Cancer Cell Line Databases for Pharmacogenomic Explorations

  2025-11-24

• Supplementary Table 3 from CellMinerCDB: NCATS Is a Web-Based Portal Integrating Public Cancer Cell Line Databases for Pharmacogenomic Explorations

  2025-11-24

• Supplementary Table 5 from CellMinerCDB: NCATS Is a Web-Based Portal Integrating Public Cancer Cell Line Databases for Pharmacogenomic Explorations

  2025-11-24

• Supplementary Table 4 from CellMinerCDB: NCATS Is a Web-Based Portal Integrating Public Cancer Cell Line Databases for Pharmacogenomic Explorations

  2025-11-24

• Supplementary Table 1 from CellMinerCDB: NCATS Is a Web-Based Portal Integrating Public Cancer Cell Line Databases for Pharmacogenomic Explorations

  2025-11-24

• CellMiner cross-database (CellMinerCDB) version 2.2 for explorations of patient-derived cancer cell line pharmacogenomics

  Nucleic Acids Research · 2025-11-14

• Data from Beyond the Promoter: Total <i>MGMT</i> Gene Methylation Modulates Response to DNA-Alkylating Agents in Glioma

  2025-10-01

• Supplemental Table 1 from Beyond the Promoter: Total <i>MGMT</i> Gene Methylation Modulates Response to DNA-Alkylating Agents in Glioma

  2025-10-01

• Supplemental Table 2 from Beyond the Promoter: Total <i>MGMT</i> Gene Methylation Modulates Response to DNA-Alkylating Agents in Glioma

  2025-10-01

• Supplemental Figure 2 from Beyond the Promoter: Total <i>MGMT</i> Gene Methylation Modulates Response to DNA-Alkylating Agents in Glioma

  2025-10-01

• Supplemental Figure 1 from Beyond the Promoter: Total <i>MGMT</i> Gene Methylation Modulates Response to DNA-Alkylating Agents in Glioma

  2025-10-01

• Protocol to set up the CellMinerCDB pharmacogenomics analysis web application with custom cell line data

  STAR Protocols · 2025-09-25 · 2 citations

• SCLC TumorMiner: A Genomics Platform for Small Cell Lung Cancer Precision OncologyPreprint

  bioRxiv (Cold Spring Harbor Laboratory) · 2025-07-10